✦ LIBER ✦

P390 Re-introduction of infliximab after consecutive failure of infliximab and adalimumab is beneficial in refractory Crohn's disease

✍ Scribed by Brandse, J.F.; Peters, C.P.; Eshuis, E.J.; Lowenberg, M.; Ponsioen, C.Y.; van den Brink, G.R.; D'Haens, G.R.A.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu1151 Re-Introduction of Infliximab Aft

✍ Brandse, Johannan F; Peters, Charlotte P.; Eshuis, Emma J.; Lowenberg, M.; Ponsi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Su1392 Benefit of Infliximab Re-Introduc

✍ Gagniere, Charlotte; Beaugerie, Laurent; Pariente, Benjamin; Seksik, Philippe; A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 420 KB

W1300 Effectiveness of Infliximab After

✍ Chaparro, Maria; Andreu, Montserrat; Barreiro, Manuel; Garcia-Planella, Esther; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Infliximab beneficial in refractory Croh

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

P173 - Efficacy of adalimumab in patient

✍ P. Cordero Ruiz; C. Catro Marquez; V. Mendez Rufian; L. Castro-Laria; á. Caunedo 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 46 KB

P006 ADALIMUMAB MAINTAINS LONG-TERM REMI

✍ R. Panaccione; W.J. Sandborn; G.R. D'Haens; R. Enns; D.C. Wolf; K.G. Lomax; P.F. 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 92 KB